Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1984-8-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0278-0232
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
74-6
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:6735351-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:6735351-Combined Modality Therapy,
pubmed-meshheading:6735351-Hodgkin Disease,
pubmed-meshheading:6735351-Humans,
pubmed-meshheading:6735351-Mediastinal Neoplasms,
pubmed-meshheading:6735351-Prognosis,
pubmed-meshheading:6735351-Recurrence,
pubmed-meshheading:6735351-Risk
|
pubmed:articleTitle |
Mediastinal involvement by Hodgkin's disease and the implications for management for those patients with local or loco-regional disease.
|
pubmed:publicationType |
Journal Article
|